Answers are grounded in this paper and cite their sources.
pharmacokinetic and pharmacodynamic studies), as well as clinical outcomes in patients with cirrhosis on DOAC.
No takes yet. Share an insight, caveat, or question.
Portela et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: